Methyl 2-amino-3,3,3-trifluoro-2-methylpropanoate; hydrochloride, 100mg

Isovanillic Acid>98.0%(HPLC)(T)25g

Norverapamil (hydrochloride), 25mg

3-Pyridin-2-yl-quinoline, 97.0%, 2g

E-Plan phase EPLPHi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm

Ethyl 5-(3-nitrophenyl)oxazole-4-carboxylate, 95.0%, 250mg

Methyl 4-ethynylbenzoate, 98.0%, 5g

Ethyl 4-chloro-6,8-difluoroquinoline-3-carboxylate, 95%, 100mg

6-TERT-BUTYL 2-ETHYL 7,8-DIHYDROPYRROLO[3,2-E]INDOLE-2,6(3H)-DICARBOXYLATE, 90.0%, 500mg

5-Fluoronaphthalen-1-ol, 95.0%, 1g

Dimethyl 3-aminothiophene-2,5-dicarboxylate, 98%, 50mg

7,8-DIFLUOROQUINOLINE, 95.0%, 1g

(5-BROMO-2-METHOXYPYRIDIN-4-YL)METHANOL, 95.0%, 250mg